Error
  • The template for this display is not available. Please contact a Site administrator.

ENT Section

ENT1

Board 2022-2024


 
Section Chair
Sanna Toppila-Salmi
Finland

Section Secretary
Valerie Hox

Section Past Chair
Ludger Klimek

Board members
Valerie Hox
Adam Chaker
Juan Maza Solano
Sietze Reitsma
Rudenko
Simon Gane

JM Representative
Aspasia Karavelia

  


-



Interview with Philippe Gevaert, Ghent University

 

Philippe Gevaert talks about the importance of interaction
between ENT specialists and immunotherapy and biologics
specialists, and highlights the importance of understanding
who to treat with these medications.


“”It is crucial to take a good product for the right patient and to
tailor it for the patient itself. Precision medicine (...) is about
combining the needs of the patient"
June 2019

 









-









-


Recommended reads

Auge et al - EAACI position paper on standardization of nasal allergen challenges

Roberts et al - EAACI Guidelines on allergen immunotherapy: Allergic rhinoconjunctivitis

Hellings et al - Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology

Hellings et al - Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUROREA-ARIA-EPOS-AIRWAYS ICP statement

Pfaar et al - Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper